Article

CRISPR-based screens uncover determinants of immunotherapy response in Multiple Myeloma

2019-11-07

Abstract excerpt

Cancer cells commonly develop resistance to immunotherapy by loss of antigen expression. Combinatorial treatments that increase levels of the target antigen on the surface of cancer cells have the potential to restore efficacy to immunotherapy. Here, we use our CRISPR interference and CRISPR activation-based functional genomics platform to systematically identify pathways controlling cell-surface expression of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dcfee1ed-d944-573c-bd2f-612dae1f633f
DOI: 10.1101/833707

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CRISPR-based screens uncover determinants of immunotherapy response in Multiple MyelomaDOI 10.1101/833707Read

CRISPR-based screens uncover determinants of immunotherapy response in multiple myelomaSemantic proximity Read

In vivo CRISPR screens identify key modifiers of CAR T cell function in myelomaSemantic proximity Read

Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for CancerSemantic proximity Read

Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screeningSemantic proximity Read

Dual chimeric antigen receptor T cells targeting CD38 and SLAMF7 with independent signalling demonstrate efficacy and safety in preclinical models of Multiple MyelomaSemantic proximity Read

CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applicationsSemantic proximity Read

Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screeningSemantic proximity Read

Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killingSemantic proximity Read

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaSemantic proximity Read

CRISPR screens establish regulatory maps of immunosuppressive surface molecules in cancerSemantic proximity Read

CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesSemantic proximity Read

Efficient Gene Editing of CART Cells with CRISPR-Cas12a for Enhanced Antitumor EfficacySemantic proximity Read